The aftermath of SARS-CoV-2 in NICU: saving or checking accounts? Projected cost-effectiveness analysis.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
May 2021
Historique:
received: 20 08 2020
accepted: 20 11 2020
revised: 13 11 2020
pubmed: 9 1 2021
medline: 28 4 2021
entrez: 8 1 2021
Statut: ppublish

Résumé

In the aftermath of the SARS-CoV-2 pandemic, we revised the cost-effectiveness of the exploited interventions in neonatal intensive care unit, to redefine future strategies for hospital management. Costs were revised with respect to the lockdown R0 or under different R0 scenarios to estimate the cost-effectiveness of the screening program adopted. Weekly nasopharyngeal swabs for parents, neonates, and personnel were the major cost during the pandemic, although they effectively reduced the number of cases in our unit.Conclusion: Parents and healthcare personnel testing appears to be an effective strategy due to the high number of contact they have within the hospital environment and outside, able to minimize the cases within our unit. What is Known: • Costs of universal COVID-19 tests for parents, neonates, and NICU personnel have not been evaluated during the COVID-19 pandemic in neonatal intensive care unit in Europe. What is New: • Weekly nasopharyngeal swabs for parents, neonates, and personnel were the major cost during the COVID-19 pandemic in NICU. • Parents and healthcare personnel testing was effective to reduce costs related to COVID-19 due to the high number of contact they have within the hospital environment and outside.

Identifiants

pubmed: 33415468
doi: 10.1007/s00431-020-03884-1
pii: 10.1007/s00431-020-03884-1
pmc: PMC7790311
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1631-1635

Références

Am J Perinatol. 2020 Jun;37(8):780-791
pubmed: 32359226
Eur J Pediatr. 2020 Dec;179(12):1945-1947
pubmed: 32785859
Healthcare (Basel). 2020 Sep 01;8(3):
pubmed: 32882820
Nat Commun. 2020 Jul 14;11(1):3572
pubmed: 32665677
Pediatr Pulmonol. 2020 Jun;55(6):1308-1310
pubmed: 32315113
Am J Perinatol. 2020 Jun;37(8):869-872
pubmed: 32359227

Auteurs

Alfonso Galderisi (A)

Department of Women's and Children's Health, University Hospital of Padova, Via N. Giustiniani, 3, 35128, Padova, Italy. alfonso.galderisi@unipd.it.

Elisabetta Lolli (E)

Department of Women's and Children's Health, University Hospital of Padova, Via N. Giustiniani, 3, 35128, Padova, Italy. elisabetta.lolli@aopd.veneto.it.

Maria Elena Cavicchiolo (ME)

Department of Women's and Children's Health, University Hospital of Padova, Via N. Giustiniani, 3, 35128, Padova, Italy.

Luca Bonadies (L)

Department of Women's and Children's Health, University Hospital of Padova, Via N. Giustiniani, 3, 35128, Padova, Italy.

Daniele Trevisanuto (D)

Department of Women's and Children's Health, University Hospital of Padova, Via N. Giustiniani, 3, 35128, Padova, Italy.

Eugenio Baraldi (E)

Department of Women's and Children's Health, University Hospital of Padova, Via N. Giustiniani, 3, 35128, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH